Biomarker Lens

Common biomarkers

  • Hemoglobin
  • Glucose
  • ALT
  • Apolipoprotein B
  • C-Reactive Protein, Cardiac
  • Ferritin
  • Alb/Creat Ratio, Urine
  • Alkaline Phosphatase
  • FSH
  • T4,Free(Direct)

Biomarkers · Chemical

LCMSMS

Also listed as
LC/MS/MS
LOINC codes
1763-2, 2915-7, 30894-0, 1668-3, 2139-4, 2143-6, 2839-9, 35384-7, 1986-9, 89324-8, 92845-7, 13457-7, 1884-6, 2085-9, 2093-3, 2571-8, 43396-1, 4548-4, 9830-1, 2345-7, 14159-8, 1656-8, 1657-6, 1674-1, 1854-9, 2196-4, 2837-3, 2986-8, 6765-2, 2991-8
Tests that measure LCMSMS
Quest Diagnostics 10

Ranges

Each lab publishes a reference range for the population groups it tests, usually the middle 95% of results. These intervals describe that population, not an optimal or healthy target. How ranges differ

Quest Diagnostics, Aldosterone/Plasma Renin Activity Ratio, LC/MS/MS 16845

PopulationInterval
AdultNot stated
PediatricNot stated
InfantsNot stated
Tanner StagesNot stated
Aldosterone, Upright 8:00-10:00 A.M.≤28 ng/dL
Aldosterone, Upright 4:00-6:00 P.M.≤21 ng/dL
Aldosterone, Supine 8:00-10:00 A.M.3-16 ng/dL
Aldosterone, 1-12 Months2-70 ng/dL
Aldosterone, 1-4 Years2-37 ng/dL
Aldosterone, 5-9 Years≤9 ng/dL
Aldosterone, 10-13 Years≤21 ng/dL
Aldosterone, 14-17 Years≤35 ng/dL
Aldosterone, Premature (31-35 Weeks)≤144 ng/dL
Aldosterone, Term≤217 ng/dL
Aldosterone, II-III Males1-13 ng/dL
Aldosterone, II-III Females2-20 ng/dL
Aldosterone, IV-V Males3-14 ng/dL
Aldosterone, IV-V Females4-32 ng/dL
Aldosterone, Plasma Renin Activity0.25-5.82 ng/mL/h
Aldosterone, Aldosterone/PRA Ratio0.9-28.9 Ratio

Quest Diagnostics test catalog, 16845

Quest Diagnostics, Cardio IQ® Insulin Resistance Panel with Score 36509

PopulationInterval
Insulin, Intact, LC/MS/MS≤16 uIU/mL
C-peptide, LC/MS/MS0.68-2.16 ng/mL
Insulin Resistance Score≤66

Quest Diagnostics test catalog, 36509

Tests

Check the catalog code, specimen, method and preparation for every test that measures LCMSMS. Select up to five tests to compare them side by side.

Quest Diagnostics 10 tests

Panels that include this biomarker

  • Aldosterone/Plasma Renin Activity Ratio, LC/MS/MS 16845

    3 analytes · Plasma · Fasting not stated

    Method and collection
    Method
    Chromatography/Mass Spectrometry
    Collection
    Collect a mid-morning blood sample after patient has been upright (sitting, standing, or walking) for a minimum of 2 hours, then have them sit 5-15 minutes prior to collection.
    Quest Diagnostics catalog page

  • Cardio IQ® Insulin Resistance Panel with Score 36509

    5 analytes · Serum · Fasting required

    Method and collection
    Method
    Immunocapture Liquid Chromatography/Tandem Mass Spectrometry
    Preparation
    Overnight fasting is required
    Collection
    Allow serum samples to clot completely before centrifugation
    Quest Diagnostics catalog page

  • Steroid Panel, Polycystic Ovary Syndrome (PCOS) 90424

    5 analytes · Serum · Fasting not stated

    Method and collection
    Method
    Chromatography/Mass Spectrometry • Equilibrium Dialysis
    Collection
    Collect specimen in a non additive red-top tube; spin down immediately and pour off into a 13x75 plastic transport tube.
    Reference notes
    See individual tests
    Quest Diagnostics catalog page

  • Metabolic Syndrome and Glucose Control Including Insulin 91398

    7 analytes · Serum · Fasting not stated

    Method and collection
    Method
    Chromatography/Mass Spectrometry • Spectrophotometry (SP)
    Preparation
    If a cholesterol measurement is to be performed along with triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required. The assay manufacturer Beckman Coulter advises: N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been determined to interfere with assays for cholesterol and uric acid where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hours and a third dose of 100 mg/kg administered over 16 hours.
    Reference notes
    See Laboratory Report
    Quest Diagnostics catalog page

  • Steroid Panel, PCOS/CAH Differentiation 90426

    7 analytes · Serum · Fasting not stated

    Method and collection
    Method
    Chromatography/Mass Spectrometry • Equilibrium Dialysis
    Collection
    Collect specimen in a no additive red-top tube. Spin down immediately and pour off into a plastic transport tube.
    Reference notes
    See individual tests
    Quest Diagnostics catalog page

0 of 5 tests selected

Pick one more

Sources

Check the guidelines, studies and lab catalogs behind every range and link on this page. Open a source to see each claim it backs.

Lab catalogs

Codes and registries

Verify these ranges and sources

We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.

Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.